A prospective study of the effect of wound closure on prevention of posterior bleeding for ulcers after endoscopic submucosal dissection (ESD) in patients taking oral antithrombotic medications - ESD study

agasaki University0 个研究点目标入组 25 人开始时间: 2024年2月28日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•(1) Patients have active multiple cancers. However, intraepithelial or intramucosal carcinoma that can be cured by endoscopic treatment is eligible. (2) The patient has the following serious complications: (i) Serious hepatic disorder Serious hepatic disorder Serious cardiac disease (myocardial infarction, angina pectoris, congestive heart failure, etc.) Serious renal disorder (3) Serious infectious disease. (4) Women who are pregnant or may become pregnant. Women who are lactating. (5) Patients with serious bleeding or in shock. (6) Patients with bleeding tendency. (7) Patients who are currently participating in another clinical trial or for whom at least 3 months have not elapsed since the completion of the trial. (8) Other patients whom the investigators/associate investigators deem inappropriate as subjects.

发起方

agasaki University